Since 2021, the story of GLP-1s has illustrated that scientific progress is rarely a straight line from hypothesis to patient ...

Risks for kidney failure and major cardiovascular events between three GLP-1 receptor agonists were similar among veterans with diabetes. Mortality risk and certain adverse events differed between the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

Please provide your email address to receive an email when new articles are posted on . Adults with OSA and type 2 diabetes prescribed tirzepatide vs. liraglutide or semaglutide had a smaller ...

Mittal said the opportunity remains meaningful despite the broader GLP-1 market shifting toward newer therapies such as ...